Request appointment
1275 York AvenueNew York, NY 10065
Overview of Dr. Sen
Dr. Filiz Sen is a pathologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Glen Cove Hospital. She received her medical degree from Marmara Univ- Fac Med and has been in practice 36 years. She is one of 32 doctors at Glen Cove Hospital and one of 175 doctors at Memorial Sloan Kettering Cancer Center who specialize in Pathology. She has more than 30 publications and over 500 citings.
Education & Training
Duke University HospitalResidency, Pathology-Anatomic and Clinical, 1998 - 2002
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pathology-Anatomic and Clinical, 1995 - 1998
Marmara Univ- Fac MedClass of 1990
Certifications & Licensure
TX State Medical License 2002 - Present
NJ State Medical License 2021 - 2027
NY State Medical License 2010 - 2027
NC State Medical License 2004 - 2006
American Board of Pathology Anatomic Pathology & Clinical Pathology- American Board of Pathology Hematology
Publications & Presentations
PubMed
- Pembrolizumab-GVD in relapsed or refractory Hodgkin lymphoma: 5-year update of a multicenter phase 2 trial.Kishan Patel, Gunjan L Shah, Heiko Schöder, Nivetha Ganesan, Esther Drill
Blood. 2026-09-08 - 1 citationsChronic lymphocytic leukemia transdifferentiated to blastic neoplasm with T/plasmacytoid dendritic cell immunophenotype.Kimon V Argyropoulos, Umut Aypar, Mark D Ewalt, Mikhail Roshal, Ahmet Dogan
Leukemia & Lymphoma. 2023-03-01 - 1 citationsSuccessful brentuximab vedotin and nivolumab therapy of multiply refractory diffuse large B-cell lymphoma with Hodgkin features.Victor Zibara, Filiz Sen, Michael Scordo, Lorenzo Falchi
Leukemia & Lymphoma. 2022-12-01
Abstracts/Posters
- Dual Driver Mutant BCR-ABL1-Negative Myeloid Neoplasms: Multicenter Clinicopathologic and Genomic AnalysisFiliz Sen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Leukemia Cell of Origin Influences p53 Activity and Therapeutic Sensitivity Via an Evi1-Dependent MechanismFiliz Sen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: